CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

shr-1209

mAbexperimental

Clinical trial activity

13 trials · 28 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
8
Phase 3
4
Phase 4
2

Earliest trial started Aug 30, 2018 (NCT03634436)

Timeline

2010s

  1. Jan 1, 2018

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2021

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07290699Phase 4Jan 1, 2026Gannan Medical University, Jiujiang First People's Hospital, Nanchang University, The First People's Hospital of Changde City, Xiangtan Central Hospital, Yueyang Central Hospital, ZhuZhou Central Hospital
NCT07119918Phase 3Sep 1, 2025Sun Yat-Sen University
NCT06902740Phase 4Sep 1, 2025Baotou Medical University, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Chinese Academy of Medical Sciences, Chongqing Medical University, Fudan University, Harbin Medical University, Hebei University, Jining NO.1 People 's Hospital, Liaocheng People's Hospital, Nanjing Medical University, People's Liberation Army of China, Qingdao University, Shiyan Taihe Hospital, Tangshan Worker's Hospital, Weifang People's Hospital, Xiamen University, Zhengzhou University
NCT07062328Phase 2Jul 10, 2025Hengrui Therapeutics, Inc., Sun Yat-Sen University
NCT07002476Phase 3Jun 30, 2025Huazhong University of Science and Technology
NCT06837077Phase 1Mar 14, 2025Hengrui Therapeutics, Inc.
NCT06467617Phase 2Jul 1, 2024Capital Medical University
NCT05370950Phase 1May 15, 2022Hengrui Therapeutics, Inc.
NCT04849000Phase 3Apr 23, 2021Hengrui Therapeutics, Inc.
NCT04844125Phase 3Apr 14, 2021Hengrui Therapeutics, Inc.
NCT04455581Phase 2Sep 1, 2020Hengrui Therapeutics, Inc.
NCT03944109Phase 1/Phase 2 (Phase 2)May 31, 2019Hengrui Therapeutics, Inc.
NCT03634436Phase 1Aug 30, 2018Hengrui Therapeutics, Inc.
Showing 13 of 13 trials
Page 1 / 1

Organizations

Research & Development (28)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Hengrui Therapeutics, Inc.For profit8732018
Sun Yat-Sen UniversityAcademic/Hospital2222025
Baotou Medical UniversityAcademic/Hospital1012025
Cangzhou Hospital of Integrated Traditional Chinese and Western MedicineAcademic/Hospital1012025
Capital Medical UniversityAcademic/Hospital1112024
Chinese Academy of Medical SciencesAcademic/Hospital1112025
Chongqing Medical UniversityAcademic/Hospital1012025
Fudan UniversityAcademic/Hospital1012025
Gannan Medical UniversityAcademic/Hospital1012026
Harbin Medical UniversityAcademic/Hospital1012025
Hebei UniversityAcademic/Hospital1012025
Huazhong University of Science and TechnologyAcademic/Hospital1112025
Jining NO.1 People 's HospitalAcademic/Hospital1012025
Jiujiang First People's HospitalAcademic/Hospital1012026
Liaocheng People's HospitalAcademic/Hospital1012025
Nanchang UniversityAcademic/Hospital1112026
Nanjing Medical UniversityAcademic/Hospital1012025
People's Liberation Army of ChinaGovernment1012025
Qingdao UniversityAcademic/Hospital1012025
Shiyan Taihe HospitalAcademic/Hospital1012025
28 organizations
Page 1 / 2